592 - PREVENTION OF ATRIAL FIBRILLATION WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS: A META-ANALYSIS
A Baranchuk, J Healey, E Crystal, C Morillo, S Yusuf, SJ Connolly
Hamilton, Ontario

593 - RANDOMIZED TRIALS OF DRONEDARONE FOR MAINTENANCE OF SINUS RHYTHM IN ATRIAL FIBRILLATION OR FLUTTER: EURIDIS AND ADONIS
SJ Connolly, D Roy, EURIDIS and ADONIS Investigators
Hamilton, Ontario; Montreal, Quebec

594 - ELECTROPHYSIOLOGICAL PROPERTIES OF AN ATRIAL SELECTIVE ANTIARRHYTHMIC AGENT, RSD1235, IN HUMANS
P Dorian, I Mangat, V Korley, GN Beatch, S Cvitkovic, A Pinter
Toronto, Ontario

595 - SLOW PATHWAY ABLATION REVISITED: DO WE NEED NEW ENERGY SOURCES?
F Philippon, J Champagne, GE O’Hara, F Molin, L Blier, JM Côté, A Dompnier, M Gilbert
Quebec City, Quebec

596 - COMBINED PULMONARY VEIN ISOLATION AND ANATOMICAL LEFT ATRIAL CATHETER ABLATION GUIDED BY A NAVIGATION SYSTEM FOR THE TREATMENT OF ATRIAL FIBRILLATION
PG Novak, PG Guerra, M Dubuc, D Roy, M Talajic, I Greiss, P Dieuzaide, A Furlani, B Thibault, L Macle
Montreal, Quebec

597 - LINEAR ABLATION OF THE LATERAL LEFT ATRIUM, IN ADDITION TO PULMONARY VEIN OSTIAL ISOLATION, REDUCES RECURRENCE OF ATRIAL FIBRILLATION
E Kotschet, A Pantano, D Adam, RA Leather, LD Sterns
Victoria, British Columbia